8 News & Press Releases found
Vektor Medical, Inc. News
-
Vektor Medical to Present Positive Results from vMap Clinical Validation Study Showing 97.3% Mapping Accuracy for Atrial and Ventricular Arrhythmias
Non-invasive arrhythmia technology maps using only the data from a 12 lead ECG vMap provides actionable mapping results in minutes. Blinded, multi-center study with analysis by an independent core laboratory Results to be presented for ...
-
Vektor Medical receives FDA clearance for vMAP, First Technology designed to identify arrhythmia hot spots anywhere in heart in minutes using only ECG data
Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or ...
-
vMap`s Role in Optimizing Non-Invasive Radio-Ablation Therapy presented at ACC.21 and THRS 2021.
A dual-center study reported that vMap™, as part of a new, non-invasive workflow - with Varian’s CRA system - improved efficiency and precision for radio-ablation therapy in these study subjects. The study showed that the ...
-
The feasibility of using vMap in patients after COVID-19 Infection presented at THRS 2021.
COVID-19 is associated with myocardial inflammation which may cause or exacerbate arrhythmias. A study led by Dr. David Krummen was presented at the Taiwan Heart Rhythm Society - Cutting-Edge Care for Heart Rhythm on April 17-18, 2021. The study ...
-
Vektor Medical Initiates Clinical Study of vMap
Vektor Medical, Inc. announced the start of its clinical study to evaluate vMap™. Using patients who have previously undergone a clinically-indicated electrophysiology study and successful ablation, the purpose of this study is to clinically ...
-
Benefits of Vektor Medical’s vMap presented at the American Heart Association’s Scientific Sessions 2020
vMap™ was presented as an innovative technology that may improve “efficiency and precision” in the treatment of complex arrhythmias. All five patients treated with vMap™ and radio-ablation experienced successful outcomes ...
-
Vektor’s vMap Technology Used Alongside SAbR Planning Software (Varian, Palo Alto, CA) for Non-Invasive Mapping and Radio-ablation of Refractory Ventricular Tachycardia
Life-threatening heart rhythm disorders such as ventricular tachycardia may be eliminated using cutting-edge, non-invasive technology as an alternative to standard invasive catheter ablation procedures, in some cases. In an abstract and associated ...
-
Vektor Medical, Inc. Successfully Closes Its Convertible Note Funding Round
Today, Vektor Medical, Inc. announces the closing of its Convertible Note funding round. The funds will be used to support research relating to and development of a non-invasive computational arrhythmia mapping device. “We’re excited to ...